Skip to main content
logo
Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
6.66
-0.01 (-0.15%)
Sep 18, 2026, 2:35 PM EDT - Market open

Precision BioSciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
45.0634.2668.748.7325.1115.53
Revenue Growth
3472.96%-50.12%40.98%94.15%-78.28%375.72%
Gross Profit
45.0634.2668.748.7325.1115.53
Operating Income
-36.4-52.15-26.16-43.74-62.31-39.38
Net Income
-52.73-45.727.17-61.32-111.64-30.6
Earnings Per Share
-2.59-3.561.04-15.96-38.10-15.64
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
87.55115.5986.31116.68189.58143.66
Total Debt
28.128.8130.0531.2724.969.11
Net Cash (Debt)
59.4586.7856.2785.41164.62134.55
Net Cash Growth
81.26%54.22%-34.12%-48.12%22.35%69.72%
Net Cash Per Share
2.926.778.1722.2356.1968.78

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-51.9-65.84-58.45-84.11-45.75-10.85
Capital Expenditures
-0.04-0.09-0.25-1.96-3.32-5.05
Free Cash Flow
-51.94-65.93-58.7-86.07-49.07-15.91
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-80.78%-152.19%-38.08%-89.76%-248.26%-34.08%
Pretax Margin
-119.00%-136.03%10.43%-87.28%-290.50%-26.49%
Profit Margin
-117.04%-133.45%10.43%-125.84%-444.80%-26.49%
FCF Margin
-115.27%-192.41%-85.44%-176.64%-195.52%-13.77%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--4.08---
PS Ratio
4.092.920.430.915.263.89